==================================== COMPANY VISION ===================================
BodyTel is a pioneer in the field of wireless health care products, with specific focus on home diagnostics. The company’s flagship product, GlucoTel, is a Java- and Bluetooth-enabled glucose metering device that provides diabetics and physicians with a better way to monitor blood glucose levels and capture related information. As a result of its convenient size, ease of use and wireless connectivity, GlucoTel has the potential to revolutionize how diabetics self-manage their disease.
Additional products from BodyTel – also leveraging wireless technologies – include PressureTel for monitoring blood pressure and WeightTel for monitoring weight.
Like GlucoTel, these new products have the power to transform how patients and caregivers manage diseases and other health conditions.
By introducing widely adopted wireless technologies to health care, BodyTel seeks to improve the quality of care and quality of life for millions of patients worldwide.
======================================= PRODUCTS ======================================
: The FIRST & ONLY Blood glucose meter using Bluetooth technology
The GlucoTel is a wireless bluetooth blood glucose meter and part of a whole system which is the perfect symbiosis between an easy to use software application for java- and bluetooth enabled mobile phones and the most powerful internet solution to manage diabetes. Glucose values are measured and transferred wirelessly and in realtime to the internet based server. Patients can access this database via a convenient web interface and can allow their doctor, diabetes educator or their family members access to this database, too. With this innovative approach, BodyTel Scientific Inc. leads the way in merging the field of medicine with the adjuvant field of telecommunication.
: Coming Soon!
: Coming Soon!
================================== DIABETES FAST FACTS =================================
* 250 million sufferers today, 350 million by 2025
* Monitoring, pharma and insulin: a $50+ billion market
* In the US, 1 in 6 healthcare dollars is spent on diabetes and conditions caused by diabetes
* Diabetes is now the number-four cause of death worldwide.
Countries with highest total number of sufferers:
India 35.5 million
China 23.8 million
USA 16 million
Russia 9.7 million
Japan 6.7 million
Pierre Lefèbvre, president of the International Diabetes Federation (IDF), the world’s most respected authority on the subject, speaking in December of 2006.
“Diabetes is fast becoming the epidemic of the 21st century.”
The New York Times: “The diabetes epidemic will overwhelm health care resources everywhere if governments do not wake up and take action.”
USA Today: “73 million have diabetes or are at risk in U.S. There’s a tremendous problem … that really represents a genuine epidemic.”
Time Magazine: In its cover story “Why Are So Many of Us Getting Diabetes?” Time called the disease “an epidemic that keeps on raging,” and said “What alarms public health experts the most is the speed at which diabetes has spread.”
Dr. Jan Bolinder, of Karolinska University Hospital Huddinge, Stockholm.
“Intensive self-monitoring of blood glucose [blood sugar] is important to achieve good metabolic control”
==================================== PRESS RELEASES ===================================
Mon, June 9, 2008
BodyTel Obtains CE Marking for the GlucoTel Blood Glucose Monitoring and Diabetes Management System
Mon, Apr 7, 2008
BodyTel Appoints Larry Rosenfeld and Paul Barry to Its Board of Directors
Mon, Mar 17, 2008
BodyTel to Display at American Telemedicine Association 2008 Meeting & Exhibition
Tue, Jan 29, 2008
BodyTel to Present GlucoTel in Muenster, Germany at Diabetes 2008
Tue, Jan 22, 2008
BodyTel Successfully Completes ISO13485 Audit
Tue, Jan 22, 2008
BodyTel Enters Into First International Distribution Agreement
Thu, Jan 17, 2008
BodyTel Scientific Moves World Headquarters to Jacksonville, Florida
Tue, Jan 8, 2008
BodyTel Submits GlucoTel Technical Files for CE Certification
Mon, Nov 19, 2007
BodyTel Launches Web Portal for Users of Its Home Diagnostics Devices
Thu, Nov 15, 2007
BodyTel Announces 2008 Production Estimates for Bluetooth Blood Sugar Meter At Medica Press Conference
Mon, Nov 12, 2007
Medica 2007: BodyTel Scientific Presents First Integrated Telehealth-Solution for Blood Sugar Monitoring and Diabetes Self-Management
Wed, Oct 31, 2007
BodyTel Scientific to Exhibit at the Kirchheim Diabetes Forum in Wiesbaden, Germany
Mon, Oct 29, 2007
BodyTel Scientific Provides Update On GlucoTel Regulatory Status
Wed, Sep 12, 2007
BodyTel Moves EMEA Headquarters to New Office Building in Bad Wildungen, Germany
Tue, Sept 4, 2007
Diabetes Industry Expert Michael Berrendorf Joins BodyTel as EMEA Sales Director
Wed, Aug 29, 2007
BodyTel Scientific to Exhibit the GlucoTel System At the Primary Healthcare Exhibition and Congress in the UAE
Wed, Aug 8, 2007
BodyTel Scientific, Inc. Announces Formation of North American Sales and Marketing Arm, BodyTel North America LLC
Fri, Jul 27, 2007
BodyTel Scientific to Exhibit At the American Association of Diabetes Educators 2007 Annual Meeting
Mon, Jul 23, 2007
BodyTel Scientific to Apply for CE Certification to Market `GlucoTel' throughout Europe
Wed, Jul 11, 2007
BodyTel Scientific Seeks FDA Approval for Its Wireless Blood Glucose Monitoring Device 'GlucoTel'
Mon, Jun 25, 2007
BodyTel Scientific Announces the Formation of BodyTel Europe GmbH
Fri, Jun 22, 2007
BodyTel Scientific's GlucoTel Meter Ready for Clinical Trials
Wed, May 09, 2007
BodyTel Scientific Inc. to Exhibit at the World's Largest Meeting and Trade Show for Telemedicine
Tue, Apr 03, 2007
BodyTel Scientific Inc. to Exhibit at the AACE Show in Seattle, USA
Wed, Mar 28, 2007
BodyTel Scientific, Inc. Applies for a Patent on Automated Glucose Test-Strip Procurement
Thu, Mar 22, 2007
BodyTel Scientific, Inc. Acquires Remaining 50% of GlucoTel Scientific
Tue, Mar 20, 2007
BodyTel Scientific, Inc. Announces Opening of Representative Office in Bad Wildungen, Germany
Fri, Mar 16, 2007
BodyTel Scientific Appoints Dr. Wesley Valdes to Scientific Advisory Board
Wed, Mar 14, 2007
BodyTel Scientific Inc. to Attend the 2007 TeleHealth Conference
Tue, Mar 13, 2007
BodyTel Scientific Inc. Launches New Corporate Web Site
Mon, Feb 19, 2007
BodyTel Scientific, Inc. Listed on Germany's Largest Stock Exchange
Wed, Jan 10, 2007
BodyTel Scientific Inc. Enters Into Joint Venture Agreement
Mon, Jan 08, 2007
BodyTel Scientific Inc. Retains Financial Communications Firm
======================================= ARTICLES ======================================
Transmitting Tests Without Wires. GlucoTel is the First Meter to Wirelessly Send Blood Glucose Results
By David Mendosa - This article originally appeared in Diabetes Health, October 2006, p. 44.
U.S. Predicts Diabetes Epidemic to Go On Unchecked
Diabetes in the US: a social epidemic
Diabetes and Its Awful Toll Quietly Emerge as a Crisis
================================ CONTACT INFORMATION ==================================
President of GlucoTel Scientific Inc. and Director of Investor Relations
ZA Consulting Inc.
BodyTel Scientific Inc.
3702 South Virginia Street, Suite G12-401
Reno, NV, 89502
34537 Bad Wildungen
tel: +49 (0)5621 96953-20
fax: +49 (0)5621 96953-37
: Clark Wilson LLP
: Integrity Stock Transfer
================================== STOCK OVERVIEW ====================================
Issued & Outstanding: 44,175,000
Public Float: 24,050,000
Over the Counter Bulletin Board (OTCBB)
Stock Symbol: BDYT
CUSIP Number: 097000103
Frankfurt Stock Exchange
Security Code No.: WKN 662218
======================================== CHART =========================================
================================= Moderator's Disclaimer ===================================
This board is for BDYT discussion purposes only and in no way a recommendation to invest or not in this stock. Any investment decisions should be based on your own due diligence and decision. You are solely responsible for your choices to buy or sell. This is a disclaimer and in no way holds the moderators legally liable for your investments.